Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.220
+0.050 (1.20%)
At close: Sep 11, 2026, 4:00 PM EDT
4.280
+0.060 (1.42%)
Pre-market: Sep 14, 2026, 4:10 AM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $440.85 million as of September 11, 2026. Its market cap has decreased by -36.36% in one year.
Market Cap
440.85M
Enterprise Value
321.69M
1-Year Change
-36.36%
Ranking
Category
Stock Price
$4.22
ChartMarket Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $440.85M, an increase of 163.98%. That is a compound annual growth rate of 18.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 406.40M | 85.74% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 462.00M |
| Cabaletta Bio | 458.62M |
| Prothena Corporation | 455.36M |
| Kyverna Therapeutics | 449.60M |
| Ginkgo Bioworks Holdings | 441.08M |
| Inhibikase Therapeutics | 429.70M |
| Vogenx | 426.16M |
| Atea Pharmaceuticals | 425.89M |